Margaret M FitzPatrick insider trades: AN2 Therapeutics (ANTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Margaret reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | ANTX | ↑ Buy | 2,098 | $5.53 | $12K | Direct | Sep 2, 2026 (1d) |
| May 28, 2025 | ANTX | ↑ Buy | 8,610 | $1.18 | $10K | Direct | May 29, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANTX insiders
Open-market trades in the last 12 months
About Margaret M FitzPatrick's insider trades
Margaret M FitzPatrick is an insider at AN2 Therapeutics (ANTX). Since May 28, 2025, Margaret has reported 2 open-market purchases worth $22K and no sales on SEC Form 4. In the last 12 months: 1 buy ($12K).
Their filings also include grants and awards (12 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.